Jefferies downgrades Biogen stock, highlights Ocrevus royalty risk and pipeline...

Published on 9 Dec 2024 on Investing.com

On Monday, Biogen Inc. (NASDAQ:BIIB) faced a downgrade from a Jefferies analyst from Buy to Hold,...

Read the rest of the article

Start tracking your investments with Statfolio

On Monday, Biogen Inc. (NASDAQ:BIIB) faced a downgrade from a Jefferies analyst from Buy to Hold,...

Investing.com 9 Dec 2024

Jefferies downgraded Biogen Inc (NASDAQ:BIIB), citing the company’s tough setup. Leqembi (lecanem...

Benzinga · via Yahoo Finance 9 Dec 2024

(NASDAQ:BIIB), has recently sold shares of the company, according to a recent SEC filing. On...

Investing.com 9 Dec 2024

Following the exact same course, the stock was allocated a grade of F on the value side, putting ...

Zacks · via Yahoo Finance 6 Dec 2024

DNLI begins dosing in the phase IIa study on BIIB122 in approximately 50 participants with...

Zacks · via Yahoo Finance 6 Dec 2024

AbCellera Biologics Inc. (NASDAQ:ABCL), a biotechnology company specializing in antibody-based dr...

Investing.com 4 Dec 2024

Why Investors Should Pay Attention to This Value Stock Finding good stocks at good prices, and...

Zacks · via Yahoo Finance 29 Nov 2024

We recently published a list of 10 Cheapest Stocks to Buy On Robinhood. In this article, we are...

Insider Monkey · via Yahoo Finance 28 Nov 2024

Alector stock falls as the phase II INVOKE-2 study evaluating AL002 in slowing disease progressio...

Zacks · via Yahoo Finance 27 Nov 2024

We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article...

Insider Monkey · via Yahoo Finance 27 Nov 2024